Browse studies

Find your next paid study

14 recruiting studies matching your filters

CSP #2038 - COVID-19 Pharmacotherapy Effectiveness in the VA Healthcare System (COPE-VA)

The purpose of this study is to comprehensively describe the temporal and geographic utilization of COVID-19 therapies used for mild to moderate disease during…

COVID-19, SARS-CoV-2 InfectionRSVInfluenza

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06160128

Phase 4

A Phase 3b/4, Open-label Study to Assess the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

The purpose of this study is to investigate the immunogenicity and safety of mRNA COVID-19 variant-containing vaccine formulations against the vaccine-matched …

SARS-CoV-2

Estimated

~$25 – $1,400

Actual pay is set by the research site.

ModernaTX, Inc.NCT06585241

Observational

Usability and Clinical Validation of the CorDx Tyfast Flu A/B/COVID-19 + RSV Multiplex Rapid Test in Anterior Nasal Samples For Over-the-Counter (OTC) Use

This will be a prospective study for the clinical validation of the CorDx Tyfast Flu A/B/COVID-19 + RSV Multiplex Rapid Test for the qualitative detection and …

SARS-CoV-2 InfectionInfluenza AInfluenza B+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

CorDx, Inc.NCT07875270

Phase 3

AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NON-HOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID-19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in the hospita…

COVID-19 SARS-CoV-2 Infection

Estimated

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT06679140

Phase 1

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

The goal of this clinical trial is to test two investigational COVID-19 booster vaccines, called CoTend-s3BXBB and CoTend-BXBB, in healthy volunteers ages 40-6…

COVID-19SARS-CoV-2 Infection

Estimated

~$500 – $11,250

Actual pay is set by the research site.

Kara ChewNCT06810934

Influenza & COVID-19 Obstetric and Perinatal Epidemiology (ICOPE) Study in India

This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during w…

InfluenzaCOVID-19SARS-COV-2 Infection+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston UniversityNCT06168019

Phase 1

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

This is an open label, phase I dose-escalation study to evaluate the safety of coronavirus-specific T cell (CST) therapy for prevention of SARS-CoV-2 infection…

SARS-CoV-2 Infection

Estimated

~$150 – $2,700

Actual pay is set by the research site.

Children's National Research InstituteNCT05141058

Phase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID (REVERSE-LC)

The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physica…

Long COVIDSars-CoV-2 InfectionCoronavirus Infections+1 more

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Wes ElyNCT06631287

Enhancing Veterans Long-COVID Care: A Cognitive-Sensorimotor Framework to Understand Gait and Balance Dysfunction

Growing evidence indicates that many people who have chronic post-acute sequelae of SARS-CoV-2 infection (PASC) will experience ongoing neurological and muscul…

Post-acute Sequelae of SARS-CoV-2 Infection

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06850350

Observational

Physiological Underpinnings of Post-Acute Sequelae of SARS CoV-2 ("Long COVID") and Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

The primary objectives of this study are to determine whether exercise training is an effective strategy for treatment of Long COVID and characterize the cardi…

Post-acute Sequelae of SARS-CoV-2 Infection

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT05566483

Dissecting Human Immune Responses To Infection With Influenza or SARS-CoV-2

The purpose of this study is to evaluate the virus-specific immune response in people who are symptomatic with confirmed influenza or COVID-19. We will study t…

InfluenzaSARS-CoV-2 (COVID-19) InfectionImmune Response of Host

Estimated

~$10 – $750

Actual pay is set by the research site.

Washington University School of MedicineNCT06848309

Phase 2

A Phase 2, Randomized, Observer-Blind, Dose Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age

This study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.

SARS-CoV-2

Estimated

~$75 – $2,800

Actual pay is set by the research site.

ModernaTX, Inc.NCT07808697